Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5F8Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,149
Award facts
- Contract value 100% obligated
- $54,148.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 22, 2026, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract has a ceiling value of $54,148.82 under firm fixed-price terms, with completion scheduled for January 23, 2026. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center for federal pharmaceutical procurement.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's role as a pharmaceutical prime vendor demonstrates its established capability to meet federal medical supply requirements through open competition and its significance within the Defense Logistics Agency's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F5F8Z?
SPE2DR26F5F8Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5F8Z worth?
The government has obligated $54,149 on SPE2DR26F5F8Z.
Is contract SPE2DR26F5F8Z an order under another contract?
Yes. SPE2DR26F5F8Z is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F8Z competed?
The extent of competition for SPE2DR26F5F8Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award